Skip to main content
OpenTrials
Completed

NCT Number: NCT02991300

BioPoly® RS Partial Resurfacing Patella Registry Study

The data registry will increase the knowledge of outcomes for treatment of focal cartilage defects of the patella treated with the BioPoly RS Patella Implant and will allow monitoring of the clinical safety and performance of the device and surgical implantation kit

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Charing Cross Hospital, London, England, United Kingdom

Loading trial locations.

About this study

The data registry will increase the knowledge of outcomes for treatment of focal cartilage defects of the patella treated with the BioPoly RS Patella Implant This study will also allow monitoring of the clinical safety and performance of the device and surgical implantation kit

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 21 years and older
  • Cartilage lesion(s) located in the facets of the patella that have failed prior therapy (conservative or surgical)
  • Symptomatic lesions classified as ICRS grade 2, 3, or 4
  • Lesion size may not exceed 3.1 cm2 and must be circumscribed by a 15 mm or 20 mm circle of normal or nearly normal (ICRS Grade 0 or 1) cartilage, with an overall depth less than 4 mm from the articulating surface
  • Subchondral bone quality sufficient to support the implant
  • Understanding and willingness to comply with the post-operative rehabilitation instructions and follow-up visits.

Exclusion criteria

  • Body mass index (BMI) ≥ 35
  • Generalized degenerative or autoimmune arthritis
  • Gout
  • Uncorrected chronic malalignment of the patella (may be corrected at the same time as the implantation of the BioPoly device).
  • Uncorrected ligamentous instability (may be corrected at the same time as the implantation of the BioPoly device).
  • Kissing lesion on femur
  • More than one implant required to accommodate lesion
  • Allergy to ultra-high molecular weight polyethylene (UHMWPE), or hyaluronan/ hyaluronic acid (HA)
  • Use with opposing articulating femoral components
  • Any concomitant painful or disabling disease of the spine, hips, or lower limbs that would interfere with evaluation of the afflicted knee
  • Pregnant, prisoner, vulnerable population, or unable to provide informed consent.

Treatment and study plan

BioPoly RS Partial Resurfacing Patella Implant

Device

Primary outcomes

  1. KOOS Subscores

    Time frame: 2 year post-op

    KOOS

  2. Kujala Anterior Knee Pain Scale

    Time frame: 2 year post-op

    Kujala

  3. Medical Outcomes Study (SF-36) for generic "quality of life"

    Time frame: 2 years post-op

    SF-36

  4. Activity using Tegner Score

    Time frame: 2 years post-op

    Tegner

  5. Pain using VAS Pain

    Time frame: 2 years post-op

    VAS Pain

Secondary outcomes

  1. Radiographic Assessment

    Time frame: Annually through 5 years post-op

    Radiographic Assessment

Sponsors and collaborators

Lead sponsor

BioPoly LLC

Industry

Registry information

Official study title

Open Label, Prospective, Consecutive Series Registry Database of BioPoly® RS Partial Resurfacing Patella Implant

Important dates

Study start
2016
Primary completion
2024
Study completion
2024
First posted
Dec 13, 2016
Registry last updated
Apr 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.